These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. Aydemir C; Oguz SS; Dizdar EA; Akar M; Sarikabadayi YU; Saygan S; Erdeve O; Dilmen U Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F164-8. PubMed ID: 20659937 [TBL] [Abstract][Full Text] [Related]
12. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. Manzoni P; Stolfi I; Pugni L; Decembrino L; Magnani C; Vetrano G; Tridapalli E; Corona G; Giovannozzi C; Farina D; Arisio R; Merletti F; Maule M; Mosca F; Pedicino R; Stronati M; Mostert M; Gomirato G; ; N Engl J Med; 2007 Jun; 356(24):2483-95. PubMed ID: 17568029 [TBL] [Abstract][Full Text] [Related]
13. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Healy CM; Campbell JR; Zaccaria E; Baker CJ Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534 [TBL] [Abstract][Full Text] [Related]
14. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Uko S; Soghier LM; Vega M; Marsh J; Reinersman GT; Herring L; Dave VA; Nafday S; Brion LP Pediatrics; 2006 Apr; 117(4):1243-52. PubMed ID: 16585321 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants. Aziz M; Patel AL; Losavio J; Iyengar A; Berven M; Schloemer N; Jakubowicz A; Mathai T; McAuley JB Pediatr Infect Dis J; 2010 Apr; 29(4):352-6. PubMed ID: 19934791 [TBL] [Abstract][Full Text] [Related]
16. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit. Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766 [TBL] [Abstract][Full Text] [Related]
17. "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. Kaufman DA Early Hum Dev; 2012 May; 88 Suppl 2():S45-9. PubMed ID: 22633513 [TBL] [Abstract][Full Text] [Related]
18. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier. Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616 [TBL] [Abstract][Full Text] [Related]
19. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. Blyth CC; Barzi F; Hale K; Isaacs D J Paediatr Child Health; 2012 Sep; 48(9):846-51. PubMed ID: 22970680 [TBL] [Abstract][Full Text] [Related]
20. Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure. Weitkamp JH; Ozdas A; LaFleur B; Potts AL J Perinatol; 2008 Jun; 28(6):405-11. PubMed ID: 18185518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]